The Psychiatric Genomics Consortium (abbreviated PGC) is a consortium of scientists dedicated to conducting meta-analyses of genome-wide association studies of psychiatric disorders.[1] It was founded in 2007, originally as the Psychiatric Genome Wide Association Consortium.[2] It is based in the laboratory of Patrick F. Sullivan at the University of North Carolina at Chapel Hill.[3] As of 2019, it includes over 800 researchers from 38 different countries.[4]
People
edit- Patrick Sullivan is the principal investigator of the PGC.[5]
- The co-chairs of the PGC's Data Access Committee are Danielle Posthuma, Stephan Ripke, and Lea Davis.
References
edit- ^ "Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis". The Lancet. 381 (9875): 1371–1379. 2013-04-20. doi:10.1016/S0140-6736(12)62129-1. ISSN 0140-6736. PMC 3714010. PMID 23453885.
{{cite journal}}: CS1 maint: PMC format (link) - ^ O'Donovan, Michael C. (2015). "What have we learned from the Psychiatric Genomics Consortium". World Psychiatry. 14 (3): 291–293. doi:10.1002/wps.20270. ISSN 2051-5545. PMC 4592644. PMID 26407777.
{{cite journal}}: CS1 maint: PMC format (link) - ^ Carey, Benedict (2014-02-03). "Blazing Trails in Brain Science". The New York Times. ISSN 0362-4331. Retrieved 2019-01-15.
- ^ "What is the PGC?". Psychiatric Genomics Consortium. UNC School of Medicine. Retrieved 2019-01-15.
- ^ "Dr. Patrick Sullivan". Center for Psychiatric Genomics. UNC School of Medicine. Retrieved 2019-01-15.